Observing the quality of life in patients with benign prostatic hyperplasia
Studio Osservazionale Sulla qualità di Vita di Pazienti Affetti da IPB in Terapia Medica e/o Sottoposti a Intervento Chirurgico
This study looks at how different treatments for benign prostatic hyperplasia affect the daily lives and well-being of patients.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 8000 (estimated) |
| Ages | 18 Years and up |
| Sex | Male |
| Sponsor | IRCCS San Raffaele Academic / other |
| Locations | 1 site (Milan, Lombardy) |
| Trial ID | NCT06182189 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on assessing the quality of life of patients diagnosed with benign prostatic hyperplasia (BPH) who are either receiving medical therapy or undergoing surgical procedures. Data will be collected through a specially designed database that captures various clinical conditions, psychological factors, and overall quality of life metrics. The study aims to provide insights into how these treatments affect patients' daily lives and well-being over time.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older who are experiencing benign prostatic hyperplasia and are either on medical therapy or scheduled for surgery.
Not a fit: Patients under 18 years old or those with mental or physical disabilities that hinder their ability to complete questionnaires will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance understanding of how BPH treatments impact patients' quality of life, leading to improved management strategies.
How similar studies have performed: While observational studies on quality of life in BPH patients exist, this specific approach focusing on a comprehensive database for statistical analysis may offer novel insights.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * subjects suffering from benign prostatic hyperplasia undergoing medical therapy and/or undergoing surgery * subjects \>= 18 years old * signature of informed consent Exclusion Criteria: * subjects \< 18 years * presence of mental or physical disability that may prevent the patient from answering the questionnaires.
Where this trial is running
Milan, Lombardy
- IRCCS Ospedale San Raffaele — Milan, Lombardy, Italy (Recruiting)
Study contacts
- Principal investigator: Andrea Salonia, MD — IRCCS Ospedale San Raffaele
- Study coordinator: Andrea Salonia, MD
- Email: salonia.andrea@hsr.it
- Phone: 02 2643 5661
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.